Reetta Peltonen

Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases

U. Stenman, H. Isoniemi, Reetta Peltonen, 2018, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resection

H. Isoniemi, T. Alanko, P. Bono, 2014, OncoTargets and therapy.

The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C‐reactive protein (CRP) is a strong negative prognostic biomarker

U. Gunnarsson, C. Haglund, C. Kersten, 2016, Journal of surgical oncology.

High TKTL1 expression as a sign of poor prognosis in colorectal cancer with synchronous rather than metachronous liver metastases

C. Haglund, J. Hagström, H. Isoniemi, 2020, Cancer biology & therapy.

High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases

C. Haglund, J. Hagström, H. Isoniemi, 2020, Oncology.

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

Antonio Duarte, Gerhard Christofori, Seppo Ylä-Herttuala, 2008, Nature.

Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases

H. Isoniemi, Reetta Peltonen, C. Dehlendorff, 2020, PloS one.

Serum Matrix Metalloproteinase-8 and Myeloperoxidase Predict Survival after Resection of Colorectal Liver Metastases

H. Isoniemi, T. Sorsa, Reetta Peltonen, 2021, Oncology.